Genevac has posted a YouTube™ video of a demo at California Gold Extractions (San Diego, USA) which compares use of a rotary evaporator and the Genevac Rocket Synergy evaporator, for the batch concentration of 2 litres of winterised cannabis extract in ethanol.
Cannabis oil extract has been used medicinally for generations to help treat a variety of conditions, and its popularity has increased considerably in recent years. Of the various extraction methods used, ethanol extraction is increasingly becoming the method of choice because of its ability to economically and effectively produce an extract with a high terpene content that is safe for consumption...
Eppendorf has been awarded the Company of the Year accolade in the SelectScience® Reviewers’ Choice Awards™ 2016, in recognition of the company’s contribution to scientific research over the past year.
The leading life science company is amongst the winners who were officially announced during a ceremony held at Pittcon 2016 in Atlanta, Georgia. The Reviewers’ Choice Awards™, added to the annual Scientists’ Choice Awards® in 2015, give laboratory scientists an opportunity to have their say by rating and reviewing companies and products that have made a significant difference to their research over the...
ZEISS industry-leading GeminiSEM 500 imaging system to enhance the MACES open access microscopy imaging facility
ZEISS announces that it is providing its GeminiSEM 500, customized for nanomaterial characterization, to the University of California Merced’s Merced Nanomaterials Center for Energy and Sensing (MACES). The University’s recent purchase will support the university’s strong nanomaterial-based research programs and aid in the Center’s research in functional nanomaterials for energy and sensing for NASA missions...
With the World Health Organisation recently declaring the Zika virus the latest international public health emergency, pressure is growing on pharmaceutical manufacturers to rapidly increase production in order to meet spikes in demand.
Leading global asset management specialist, EquipNet Inc., has witnessed an increase in the number of pharma businesses purchasing pre-owned assets from other top-tier manufacturers to upscale production, as they realise the substantial time and cost savings that can be made. Ben Potenza, Vice President of Marketing at EquipNet, comments, “Pre-owned equipment is generally available immediately and delivery can be...
Discovery Park’s reputation as a centre for science innovation is set to grow even further in the months ahead thanks to a new investment fund located at the Sandwich site.
NCL Innovation, the UK’s leading early stage technology investor, has set up the Discovery Park Technology Investment Fund, which will help cutting edge science and technology firms to get their products or treatments to market. The new fund is managed by NCL and supported by Kent County Council and the Regional Growth Fund with the companies supported by the scheme given the investment and backing they...
PhoreMost Ltd (PhoreMost), a biopharmaceutical company focused on increasing the diversity and affordability of novel therapeutics, announced today that it has entered into an alliance with The Wistar Institute to identify and de-orphan novel targets in cancer, aging and the immune system.
The majority of disease driving targets are currently considered ‘undruggable’, because at first glance they appear structurally resistant to chemical intervention, especially when viewed outside of a cell in a static crystalized form. PhoreMost has developed SITESEEKER®, a new ‘phenotypic’ screening platform that exploits the dynamics of a live-cell environment to uncover hidden druggable target sites across the...
The Edinburgh Instruments applications team and Dr Gianluca Accorsi, a Research Fellow at CNR Nanotec in Lecce, Italy, worked on the photo-physical properties of Egyptian blue pigment using our Fluorescence Spectrometers.
The interest in non-invasive investigations for the study and identification of painting materials has greatly increased during the past two decades. The nature of museum objects is such that sampling is always kept to a minimum, thus, a spectroscopic approach is ideal for this purpose. An ancient pigment, cuprorivaite, CaCuSi4O10 or otherwise called Egyptian blue, has been photo-physically investigated. The investigation includes qualitative information...
The new All-Party Parliamentary Group (APPG) on Personalised Medicine held its official launch event in the House of Commons today with Life Sciences Minister George Freeman.
The Group aims to help the NHS and patients make best use of the increasing availability of cutting-edge technologies to provide more personalised health and care. The PHG Foundation, an independent health policy think tank that aims to make science work for health, provides the Secretariat for the new Group, supported by partners the Northern Health Science Alliance (NHSA), the Wellcome Trust Sanger Institute and...
Fundraise will support commercial expansion and translational product development
Cambridge Epigenetix (CEGX), a pioneer in the development of epigenetic sequencing technologies, today announced the close of a $21 million Series B financing and the appointment of Dr. Geoff Smith as CEO. The round was led by GV (formerly Google Ventures), with significant participation from Sequoia Capital. Current investors New Science Ventures, Syncona Partners and Cambridge University also joined the round...
Atlas Genetics Ltd, the ultra- rapid Point-Of-Care (POC) molecular diagnostics company, today announces that it has been awarded an SBRI grant from Innovate UK to assist in the development of an ultra-rapid POC multiplex STI test measuring the four most commonly occurring pathogens (Chlamydia trachomatis, Neisseria gonorrhoea, Trichomonas vaginalis and Mycoplasma genitalium) in less than 30 minutes.
Atlas Genetics will develop an ultra-rapid POC stratified medicine diagnostic for patients presenting to Sexual Health Clinics with urethritis, which will allow immediate and accurate selection of appropriate and effective antibiotic treatment. Atlas will be collaborating with the Applied Diagnostic Research and Evaluation Unit at St George’s, University of London and Aquarius Population Health. Key elements of this project include...
Integrated DNA Technologies (IDT), the global leader in nucleic acid synthesis, announces its 2016 Platinum Level sponsorship of the International Genetically Engineered Machine (iGEM) competition.
The iGEM Foundation conducts a yearly international competition for students interested in synthetic biology. Last year, more than 280 teams from 39 countries participated in the competition. IDT also will provide each registered team with up to 20KB of its market leading gBlocks® Gene Fragments synthetic DNA products—for a total value of almost US$1M. “We are very proud to continue our support of iGEM teams that enable...
Universities of Dundee (Scotland), & Cape Town (South Africa) partnering with Bayer (Germany)
World-leading medicinal chemistry and biology at the Universities of Dundee (Scotland) and Cape Town (South Africa) have been allied to the industrial expertise of the Pharmaceuticals Division of Bayer (Germany), one of the world’s leading pharma companies, in an effort to develop critically needed new treatments for tuberculosis (TB). The collaboration combines some of the world’s best knowledge on TB biology, drug...
People with a specific gene mutation have a 50 percent lower risk of suffering a heart attack.
This is what an international team of researchers headed by the cardiologist Prof. Heribert Schunkert, Medical Director of the German Heart Center at the Technical University of Munich (TUM), discovered in a broad comparative study. If this gene were switched off with medications it could reduce the risk of coronary disease significantly. An international research group headed by the cardiologist Prof. Heribert Schunkert...
£42 million Centre for Medicine achieves record level of energy efficiency
You can watch and share the Centre for Medicine building video here: https://www.youtube.com/watch?v=WLXKd_ULxUc. The University of Leicester’s cutting-edge new Centre for Medicine building, built by contractor Willmott Dixon and designed by Associated Architects, has officially received Passivhaus Certification – officially making it the largest Passivhaus building in the UK. Developed in Germany in the early...
Specialised Imaging reports on a technical article, written by researchers from the King Abdullah University of Science and Technology, Saudi Arabia that describes the use of a Kirana ultra high-speed video system to undertake time-resolved imaging of a compressible air disk that forms under a drop impacting on a solid surface.
The capture of a bubble under an impacting drop can have detrimental effects on the uniformity of spray coatings and interfere with precision inkjet-based manufacturing such as are used in the printing of organic displays. When a drop impacts on a solid surface, its rapid deceleration is cushioned by a thin layer of air, which leads to the entrapment of a bubble under its centre. For large impact velocities the lubrication pressure in...
Sartorius Stedim Biotech (SSB) today announced a new paper entitled, ‘Shortening Timelines for Upstream Bioprocessing of Protein-based Therapeutics’ has been published in the journal, BioPharma Asia.
The paper details how scientists at leading Asian pharmaceutical company, WuXi AppTec are using the ambr® 15 automated micro bioreactor system to mimic bench-top and production scale bioreactors, producing comparable results with cell growth, cell metabolism and protein production, including similar protein titre to BIOSTAT® STR single-use bioreactors.In the article, one case study describes how...
Researchers working on the European Metrology Research Project NanoChOp (Chemical and Optical Characterization of Nanomaterials in Biological Systems), funded by EURAMET, have concluded that the NanoSight Nanoparticle Tracking Analysis system from Malvern Instruments offers unique insight into the behavior of nanoparticles in biological systems.
Such insight supports ongoing efforts to assess the potential risks to human health posed by the increasing use of nanomaterials. Dorota Bartczak, Researcher in Inorganic Analysis at LGC commented that ”Measurement methods and techniques that provide reliable data for researchers to understand how nanoparticles behave in complex biological systems are crucial for the human risks assessments needed to ensure that the...
The Kircher laboratory at Memorial Sloan Kettering is developing novel nanoprobes for molecular imaging, image-guided therapy and theranostics.
Its ultimate goal is to develop a universal technology that allows precise determination of the actual spread of a tumour in vivo. Currently surgeons cannot see the microscopic extent of the tumour during a procedure, which is essential information for tumor removal and avoiding excess tissue excision. Physician-scientist Dr. Moritz Kircher is working on a new generation of nanometer-sized imaging beacons. These allow...
Amedica's Silicon Nitride Performed 400% Better Than PEEK in Recent Cell Adhesion Study
Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, is pleased to announce a collaboration with Celling Biosciences, a leader in autologous cellular therapy technologies, to research and develop biologically enhanced implants. As part of the initial phase of the collaboration, Celling Biosciences' team of scientists produced research indicating mesenchymal...
We bring you more exciting news about Photonex London Roadshow.
The programme has now been finalised with an excellent calibre of speakers set to give presentations. Attend this event to broaden your knowledge in the world of photonics by attending a key meeting for photonics technologies in the life sciences. The technical committee have commented that this international quality 'invited' programme includes presentations by eminent and leading European research scientists...
Dr Graham Rideal, CEO of particle sizing standards company Whitehouse Scientific, will present an image analysis technique to ensure accurate, robust and reproducible particle size measurements at PARTEC 2016, the International Congress on Particle Technology (Nürnberg, Germany: 19-21 April 2016), in a paper entitled Particle size analysis – Investigating Measurement Uncertainties in the Development of a Robust Validation.
Participating in the Applications of Particle Technology session at PARTEC, Dr Rideal will speak on the challenges of proving that the imaging technique employed measures the correct dimension constantly and consistently throughout the analysis process. His paper investigates methods to ensure the validity of results and addresses all the elements that could be challenged in proving an unbroken link to the international definition of the...
World renowned standards company, Whitehouse Scientific, will exhibit its unique range of filter calibration products and services on Booth A1212 at the 12th World Filtration Congress (Taipei International Convention Center, Taiwan: 11-15th April 2016).
Dr Graham Rideal, CEO of Whitehouse Scientific, will also present a paper on the latest developments in wet challenge testing to accurately define pore size in a filter, to an audience of scientists, engineers and practitioners operating in the filtration field. Dr Rideal™s presentation, Latest Developments in Wet Challenge Testing, will highlight the importance of being able to accurately measure maximum pore size in filters across a wide...
Cannabis oil extract has been used medicinally for generations to help treat a variety of conditions, and its popularity has increased considerably in recent years. Of the various extraction methods used, ethanol extraction is increasingly becoming the method of choice because of its ability to economically and effectively produce an extract with a high terpene content that is safe for consumption...
The leading life science company is amongst the winners who were officially announced during a ceremony held at Pittcon 2016 in Atlanta, Georgia. The Reviewers’ Choice Awards™, added to the annual Scientists’ Choice Awards® in 2015, give laboratory scientists an opportunity to have their say by rating and reviewing companies and products that have made a significant difference to their research over the...
ZEISS announces that it is providing its GeminiSEM 500, customized for nanomaterial characterization, to the University of California Merced’s Merced Nanomaterials Center for Energy and Sensing (MACES). The University’s recent purchase will support the university’s strong nanomaterial-based research programs and aid in the Center’s research in functional nanomaterials for energy and sensing for NASA missions...
Leading global asset management specialist, EquipNet Inc., has witnessed an increase in the number of pharma businesses purchasing pre-owned assets from other top-tier manufacturers to upscale production, as they realise the substantial time and cost savings that can be made. Ben Potenza, Vice President of Marketing at EquipNet, comments, “Pre-owned equipment is generally available immediately and delivery can be...
NCL Innovation, the UK’s leading early stage technology investor, has set up the Discovery Park Technology Investment Fund, which will help cutting edge science and technology firms to get their products or treatments to market. The new fund is managed by NCL and supported by Kent County Council and the Regional Growth Fund with the companies supported by the scheme given the investment and backing they...
The majority of disease driving targets are currently considered ‘undruggable’, because at first glance they appear structurally resistant to chemical intervention, especially when viewed outside of a cell in a static crystalized form. PhoreMost has developed SITESEEKER®, a new ‘phenotypic’ screening platform that exploits the dynamics of a live-cell environment to uncover hidden druggable target sites across the...
The interest in non-invasive investigations for the study and identification of painting materials has greatly increased during the past two decades. The nature of museum objects is such that sampling is always kept to a minimum, thus, a spectroscopic approach is ideal for this purpose. An ancient pigment, cuprorivaite, CaCuSi4O10 or otherwise called Egyptian blue, has been photo-physically investigated. The investigation includes qualitative information...
The Group aims to help the NHS and patients make best use of the increasing availability of cutting-edge technologies to provide more personalised health and care. 
Cambridge Epigenetix (CEGX), a pioneer in the development of epigenetic sequencing technologies, today announced the close of a $21 million Series B financing and the appointment of Dr. Geoff Smith as CEO. The round was led by GV (formerly Google Ventures), with significant participation from Sequoia Capital. Current investors New Science Ventures, Syncona Partners and Cambridge University also joined the round...
Atlas Genetics will develop an ultra-rapid POC stratified medicine diagnostic for patients presenting to Sexual Health Clinics with urethritis, which will allow immediate and accurate selection of appropriate and effective antibiotic treatment. Atlas will be collaborating with the Applied Diagnostic Research and Evaluation Unit at St George’s, University of London and Aquarius Population Health. Key elements of this project include...
The iGEM Foundation conducts a yearly international competition for students interested in synthetic biology. Last year, more than 280 teams from 39 countries participated in the competition. IDT also will provide each registered team with up to 20KB of its market leading gBlocks® Gene Fragments synthetic DNA products—for a total value of almost US$1M. “We are very proud to continue our support of iGEM teams that enable...
World-leading medicinal chemistry and biology at the Universities of Dundee (Scotland) and Cape Town (South Africa) have been allied to the industrial expertise of the Pharmaceuticals Division of Bayer (Germany), one of the world’s leading pharma companies, in an effort to develop critically needed new treatments for tuberculosis (TB). The collaboration combines some of the world’s best knowledge on TB biology, drug...
This is what an international team of researchers headed by the cardiologist Prof. Heribert Schunkert, Medical Director of the German Heart Center at the Technical University of Munich (TUM), discovered in a broad comparative study. If this gene were switched off with medications it could reduce the risk of coronary disease significantly. An international research group headed by the cardiologist Prof. Heribert Schunkert...
You can watch and share the Centre for Medicine building video here: https://www.youtube.com/watch?v=WLXKd_ULxUc. The University of Leicester’s cutting-edge new Centre for Medicine building, built by contractor Willmott Dixon and designed by Associated Architects, has officially received Passivhaus Certification – officially making it the largest Passivhaus building in the UK. Developed in Germany in the early...
The capture of a bubble under an impacting drop can have detrimental effects on the uniformity of spray coatings and interfere with precision inkjet-based manufacturing such as are used in the printing of organic displays. When a drop impacts on a solid surface, its rapid deceleration is cushioned by a thin layer of air, which leads to the entrapment of a bubble under its centre. For large impact velocities the lubrication pressure in...
The paper details how scientists at leading Asian pharmaceutical company, WuXi AppTec are using the ambr® 15 automated micro bioreactor system to mimic bench-top and production scale bioreactors, producing comparable results with cell growth, cell metabolism and protein production, including similar protein titre to BIOSTAT® STR single-use bioreactors.In the article, one case study describes how...
Such insight supports ongoing efforts to assess the potential risks to human health posed by the increasing use of nanomaterials. Dorota Bartczak, Researcher in Inorganic Analysis at LGC commented that ”Measurement methods and techniques that provide reliable data for researchers to understand how nanoparticles behave in complex biological systems are crucial for the human risks assessments needed to ensure that the...
Its ultimate goal is to develop a universal technology that allows precise determination of the actual spread of a tumour in vivo. Currently surgeons cannot see the microscopic extent of the tumour during a procedure, which is essential information for tumor removal and avoiding excess tissue excision. Physician-scientist Dr. Moritz Kircher is working on a new generation of nanometer-sized imaging beacons. These allow...
Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, is pleased to announce a collaboration with Celling Biosciences, a leader in autologous cellular therapy technologies, to research and develop biologically enhanced implants. As part of the initial phase of the collaboration, Celling Biosciences' team of scientists produced research indicating mesenchymal...
The programme has now been finalised with an excellent calibre of speakers set to give presentations. Attend this event to broaden your knowledge in the world of photonics by attending a key meeting for photonics technologies in the life sciences. The technical committee have commented that this international quality 'invited' programme includes presentations by eminent and leading European research scientists...
Participating in the Applications of Particle Technology session at PARTEC, Dr Rideal will speak on the challenges of proving that the imaging technique employed measures the correct dimension constantly and consistently throughout the analysis process. His paper investigates methods to ensure the validity of results and addresses all the elements that could be challenged in proving an unbroken link to the international definition of the...
Dr Graham Rideal, CEO of Whitehouse Scientific, will also present a paper on the latest developments in wet challenge testing to accurately define pore size in a filter, to an audience of scientists, engineers and practitioners operating in the filtration field. Dr Rideal™s presentation, Latest Developments in Wet Challenge Testing, will highlight the importance of being able to accurately measure maximum pore size in filters across a wide...